The fund closed well above its original target.

European life science venture capital firm Forbion has this week announced the close of its fourth fund, Forbion IV, at €360m ($410m) – well above its original $290m target.

The fund has been backed by a range of public and private sector investors, including the EU-backed European Investment Fund and the German government-owned bank KfW, both of which had previously supported Forbion funds.